In many human cancers, an abnormally hyperactivated IL-6/STAT3 signaling has been observed in tumor cells and cells of the tumor microenvironment, and pro-tumorigenic characteristics of both, IL-6 and STAT3, have been described7–9. This evidence concerns the gene STAT3 and neoplasm.